🇺🇸 FDA
Patent

US 6482803

Modification of mutated P53 gene in tumors by retroviral delivery of ribozyme A

expired A61KA61K48/00

Quick answer

US patent 6482803 (Modification of mutated P53 gene in tumors by retroviral delivery of ribozyme A) held by The Board of Regents of the University of Texas System expires Mon Nov 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 19 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K48/00